Description
Manufacturer:
Boehringer Ingelheim India Pvt Ltd
Salt Composition:
Empagliflozin + Linagliptin
Description:
Glyxambi 10/5mg Tablet is a combination medication used to lower blood sugar levels in adults with type 2 diabetes. It contains two active ingredients with complementary mechanisms of action: empagliflozin and linagliptin. Empagliflozin is an SGLT2 inhibitor that increases glucose excretion from the kidneys.
Linagliptin is a DPP-4 inhibitor that enhances the action of incretin hormones, leading to increased insulin release and decreased glucagon secretion. The “10/5” indicates that each tablet contains 10mg of empagliflozin and 5mg of linagliptin. Glyxambi is taken once daily.
Common side effects may include urinary tract infections, genital infections, and nasopharyngitis. It is important for patients to follow dietary and exercise recommendations while taking this medication.
Reviews
There are no reviews yet.